The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 25, 2020

Filed:

Jan. 31, 2018
Applicant:

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

Barbara Slusher, Kingsville, MD (US);

Jonathan Powell, Baltimore, MD (US);

Assignee:

THE JOHNS HOPKINS UNIVERSITY, Baltimore, MD (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/223 (2006.01); A61K 31/4045 (2006.01); A61K 38/05 (2006.01); A61K 31/655 (2006.01); A61K 39/395 (2006.01); A61K 31/22 (2006.01); A61K 31/225 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4045 (2013.01); A61K 31/22 (2013.01); A61K 31/223 (2013.01); A61K 31/225 (2013.01); A61K 31/655 (2013.01); A61K 38/05 (2013.01); A61K 39/39541 (2013.01);
Abstract

The disclosure provides methods of treating a condition, disease, or disorder in a subject that involves metabolically reprogrammed cells whose activation, function, growth, proliferation, or survival depends on increased activity of at least one metabolic pathway selected from the group consisting of glutamine metabolism, glycolysis, and fatty acid synthesis, comprising administering to the subject a compound having formula (I): and the pharmaceutically acceptable salts thereof, wherein R, R, R', and X are as defined as set forth in the specification. Compounds having formula (I) are prodrugs that release glutamine analogs, e.g., 6-diazo-5-oxo-L-norleucine (DON).


Find Patent Forward Citations

Loading…